You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tq-b3525

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Kidney Diseases, Magnetic Resonance Imaging Trial in Suzhou (TQ-B3525)

Not yet recruiting
  • Chronic Kidney Diseases
  • Magnetic Resonance Imaging
  • TQ-B3525
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jan 10, 2023

Peripheral T-cell Lymphoma Trial in Beijing, Shanghai (TQ-B3525)

Unknown status
  • Peripheral T-cell Lymphoma
  • TQ-B3525
  • Beijing, Beijing, China
  • +1 more
Oct 30, 2020

HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer Trial in China (TQ-B3525, Fulvestrant injection)

Unknown status
  • HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer
  • TQ-B3525
  • Fulvestrant injection
  • Beijing, Beijing, China
  • +3 more
Apr 20, 2020

Relapsed / Refractory Mantle Cell Lymphoma (MCL) Trial in China (TQ-B3525)

Unknown status
  • Relapsed / Refractory Mantle Cell Lymphoma (MCL)
  • TQ-B3525
  • Hefei, Anhui, China
  • +38 more
Sep 10, 2020

Relapsed / Refractory Follicular Lymphoma Trial in China (TQ-B3525)

Recruiting
  • Relapsed / Refractory Follicular Lymphoma
  • TQ-B3525
  • Hefei, Anhui, China
  • +40 more
Jun 30, 2020

Relapsed or Refractory Lymphoma or Advanced Cancer Trial in Tianjin (TQ-B3525)

Unknown status
  • Relapsed or Refractory Lymphoma or Advanced Cancer
  • TQ-B3525
  • Tianjin, Tianjin, China
    People's Hospital of Tianjin
Apr 26, 2018